July 1 (Reuters) - Artivion Inc AORT.N :
* ARTIVION AMENDS AGREEMENTS WITH ENDOSPAN
* ARTIVION INC: PROVIDES ENDOSPAN WITH $25 MILLION OF
ADDITIONAL
DEBT FUNDING TO OBTAIN FDA APPROVAL FOR NEXUS
* ARTIVION INC - UPFRONT PAYMENT ASSOCIATED WITH PURCHASE
OPTION
REDUCED TO $135 MILLION, INCLUSIVE OF LOAN OFF-SET, AND $100
MILLION EARNOUT MINIMUM ELIMINATED
* ARTIVION INC: UPFRONT PAYMENT ASSOCIATED WITH PURCHASE
OPTION IS
REDUCED FROM $250 MILLION TO $175 MILLION
* ARTIVION INC - DOES NOT ANTICIPATE AMENDED AGREEMENT WITH
ENDOSPAN TO HAVE A MATERIAL IMPACT ON ITS FULL-YEAR 2024
FINANCIAL GUIDANCE.
* ARTIVION INC: $100 MILLION MINIMUM PAYOUT FOR EARNOUT IS
ELIMINATED
Source text for Eikon: ID:nPnb2D4fQa
Further company coverage: AORT.N
((Reuters.Briefs@thomsonreuters.com;))